Alkermes plc
NASDAQ: ALKS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard F. Pops
- Employees
- 1,800
- Headquarters
- Dublin, United States
- IPO year
- 1991
- Market cap
- $7.5B
- Website
- https://www.alkermes.com
Loading ALKS…
Loading profile data…Frequently asked questions about ALKS
What does Alkermes plc (ALKS) do?
Alkermes plc is an Irish-headquartered biopharmaceutical firm, established in 1987, focused on the discovery, development, and commercialization of innovative pharmaceutical treatments. These efforts are directed at fulfilling critical unmet medical needs for patients across a range of therapeutic areas, both domestically and internationally. It...
Where does ALKS trade?
Alkermes plc (ALKS) trades on the NASDAQ Global Select.
What sector is ALKS in?
Alkermes plc (ALKS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Alkermes plc?
Richard F. Pops is the chief executive officer of Alkermes plc (ALKS).
Where is Alkermes plc headquartered?
Alkermes plc is headquartered in United States.
Does ALKS pay a dividend?
Alkermes plc (ALKS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALKS go public?
Alkermes plc (ALKS) completed its initial public offering in 1991.